Generation of induced pluripotent stem cell line, ICGi033-A, by reprogramming peripheral blood mononuclear cells from

Elena V Grigor'eva1, Anastasia A Malakhova1, Diana A Sorogina2

  • 1Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Novosibirsk, Russia; E. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation, Novosibirsk, Russia; Institute of Chemical Biology and Fundamental Medicine, the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.

Stem Cell Research
|July 25, 2022
PubMed

Insights

Huntington's disease (HD) is a neurodegenerative disorder caused by expanded CAG repeats in the huntingtin (HTT) gene. Researchers generated induced pluripotent stem cells (iPSCs) from an HD patient for disease modeling.

Area of Science:

  • Neurodegenerative Diseases
  • Stem Cell Biology
  • Genetics

Background:

  • Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder.
  • It results from polyglutamine expansion in the huntingtin (HTT) protein, leading to striatal neuron death.
  • Understanding HD pathogenesis requires cellular models.

Purpose of the Study:

  • To generate and characterize induced pluripotent stem cells (iPSCs) from a Huntington's disease patient.
  • To establish a cellular model for studying HD mechanisms.

Main Methods:

  • Peripheral blood mononuclear cells were collected from an HD patient with 77 CAG repeats in the HTT gene.
  • Cells were reprogrammed into induced pluripotent stem cells (iPSCs).
  • iPSCs were analyzed for pluripotency markers, karyotype stability, and differentiation potential.

Main Results:

  • A stable iPSC line (ICGi033-A) was successfully generated from the HD patient.
  • These iPSCs expressed key pluripotency markers.
  • The iPSC line exhibited a normal karyotype and could differentiate into all three germ layers (endoderm, ectoderm, mesoderm).

Conclusions:

  • The generated iPSC line (ICGi033-A) is a valuable tool for Huntington's disease research.
  • This model holds potential for studying disease mechanisms and therapeutic strategies in vitro.
  • The differentiation capacity of these iPSCs supports their utility in regenerative medicine approaches for HD.

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.3K